News
Jun 24, 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 24, 2024-- Alnylam Pharmaceuticals, Inc.external link, opens in a new tab (Nasdaq: ALNY), the leading RNAi therapeutics…
Jun 18, 2024
Who: Alnylam Patient Education Liaison, Karen, joined by Ambassador, Jean, living with hATTR amyloidosis and Sonia Caraballo-Cartagena, MD Neuromuscular…
May 24, 2024
OverviewISAP examines the effects of oral semaglutide, a glucagon-like protein-1 receptor agonist used for diabetes, on the build-up of proteins in the brain…
Apr 27, 2024
When:
Saturday, April 27, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Goldberg Auditorium…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Rood Pavilion…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:30-9:00AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Reform Congregation…
Apr 20, 2024
If you are from Kansas, Nebraska, Missouri, Iowa, Arkansas, Oklahoma, or anywhere else, know you are welcome.
When:
Saturday, April 20, 2024
AL will meet in the…
Apr 15, 2024
A recently granted patent (Publication Number: US11912759B2) discloses an antibody designed to bind to human transthyretin. The antibody comprises specific amino…
Mar 01, 2024
https://www.oneamyloidosisvoice.com/wp-content/uploads/2024/03/Full-Article-hATTR-Holistic-Care-Con…
Mar 01, 2024
"Light the Night for Amyloidosis" is an Amyloidosis Foundation awareness campaign created to draw attention to amyloidosis symptoms, diagnosis, treatment and…